MedTrace Logo

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

NCT04339998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2023-01-04

No results posted yet for this study

Summary

Specific Aims:

1. The investigators will prospectively evaluate and analyze changes in the appearance of the lungs and heart through serial acquisition of focused point-of-care ultrasound images in a cohort of patients with or under investigation for COVID-19.
2. The investigators will correlate changes noted in ultrasound with clinical course and diagnostic evaluation to ascertain whether changes on ultrasound could improve care through earlier diagnosis or identification of patients at high risk of disease progression.

Conditions

Interventions

DIAGNOSTIC_TEST

Point-of-Care Ultrasonography (POCUS)

The POCUS exam of the heart will capture 2 standard views commonly used to assess general cardiac function at the point of care. The details of POCUS views and exam findings of interest are outline below: Pulmonary POCUS Evaluation: 1. B lines: absent (\< 3 lines), present (\> 3 lines), fused 2. Consolidation: yes or no a. Bilateral: yes or no 3. Pleural Effusion: yes or no 4. Other pleural abnormalities: yes or no Score each finding based on degree of abnormalities and number of sites with abnormalities Cardiac POCUS Evaluation: 1. Parasternal long axis 2. Parasternal short axis 1. Qualitative LVEF: Normal, hyperdynamic, mild-moderately depressed, severely depressed 2. EPSS (E-point septal separation): normal (\<10 mm), abnormal (\>10 mm) 3. Left ventricular (LV) mass approximation by septal thickness 4. Left Ventricular Chamber Size by internal diameter at diastole

Sponsors & Collaborators

Principal Investigators

  • Matthew Yocum, MD · University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04339998 on ClinicalTrials.gov